07.09.15
Farmingdale, N.J.-based Misonix Inc., which makes ultrasonic surgical devices, has released a faster version of its Sonicone OOR (operating room) ultrasonic wound debridement procedure. The faster procedure is enabled by a new single-use disposable debridement probe with increased ultrasonic amplitude. This probe is meant to allow surgeons using the Sonicone device to reduce procedure time by up to 50 percent.
“The addition of the new, faster ultrasound assisted debridement procedure to the Sonicone OR system will allow me to utilize the already proven advantages in wound care to larger, more complex wound surfaces,” said Peter Blume, DPM, FACFAS, assistant clinical professor of orthopedics and rehabilitation in the department of orthopedics, Section of Podiatric Surgery at the Yale University School of Medicine in New Haven, Conn. “This creates an opportunity to treat a larger segment of the patient population, who had not previously been eligible for the benefits of this approach.”
“The benefits of ultrasonic debridement have been well received by the wound community,” said Michael A. McManus, Jr., president and CEO of Misonix. “Our latest advancement in bringing speed to the Sonicone product line allows users to take advantage of those ultrasonic benefits without compromising procedure times. These advancements extend our leadership position in the wound debridement field.”
“The addition of the new, faster ultrasound assisted debridement procedure to the Sonicone OR system will allow me to utilize the already proven advantages in wound care to larger, more complex wound surfaces,” said Peter Blume, DPM, FACFAS, assistant clinical professor of orthopedics and rehabilitation in the department of orthopedics, Section of Podiatric Surgery at the Yale University School of Medicine in New Haven, Conn. “This creates an opportunity to treat a larger segment of the patient population, who had not previously been eligible for the benefits of this approach.”
“The benefits of ultrasonic debridement have been well received by the wound community,” said Michael A. McManus, Jr., president and CEO of Misonix. “Our latest advancement in bringing speed to the Sonicone product line allows users to take advantage of those ultrasonic benefits without compromising procedure times. These advancements extend our leadership position in the wound debridement field.”